Skip to main content
. 2012 May 30;14(10):910–917. doi: 10.1111/j.1463-1326.2012.01618.x

Table 3.

Hypoglycaemia by sulfonylurea use at screening

Lixisenatide Placebo


Sulfonylurea use at screening Yes (n = 108) No (n = 46) Yes (n = 111) No (n = 46)
Patients with symptomatic hypoglycaemia, n (%) 51 (47.2%) 15 (32.6%) 24 (21.6%) 13 (28.3%)
 Events / patient year, n 3.54 1.48 1.48 1.36
 Patients with blood glucose <60 mg/dl, n (%) 46 (42.6%) 13 (28.3%) 21 (18.9%) 11 (23.9%)